CD274 and osteosarcoma: Moreover, CD80 and CD86 expression on metastatic osteosarcoma was significantly increased after α-PD-L1 mAb treatment suggesting that tumor cells may be directly or indirectly using this pathway to suppress CTL-mediated killing (Figure 1B).